Abstract
Patients carrying mutations in BRCA1 or BRCA2 tumor suppressor genes have shown to have high risk in developing breast and ovarian cancers. Two potential functions of BRCA2 were proposed which includes role in the regulation of transcription and also in DNA repair. Forty-five-amino acid region encoded by exon 3 of BRCA2 was shown to have transcriptional activation function. Recent studies of the several enzymes involved in acetylation and deacetylation of histone residues have revealed a possible relationship between gene transcriptional activation and histone acetylation. Since BRCA2 appear to function as a transcriptional factor, we have tested for Histone acetyl transferase (HAT) activity of BRCA2. Here, we present evidence that BRCA2 has intrinsic HAT activity, which maps to the amino-terminal region of BRCA2. Our results demonstrate that BRCA2 proteins acetylate primarily H3 and H4 of free histones. These observations suggest that HAT activity of BRCA2 may play an important role in the regulation of transcription and tumor suppressor function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Siddique, H., Zou, JP., Rao, V. et al. The BRCA2 is a histone acetyltransferase. Oncogene 16, 2283–2285 (1998). https://doi.org/10.1038/sj.onc.1202003
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202003
Keywords
This article is cited by
-
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Nature Reviews Cancer (2013)
-
Establishment of a PCR analysis method for canine BRCA2
BMC Research Notes (2012)
-
Is there more to BARD1 than BRCA1?
Nature Reviews Cancer (2006)
-
Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma
Journal of Neuro-Oncology (2006)
-
Role of BRCAgene dysfunction in breast and ovarian cancer predisposition
Breast Cancer Research (2000)